Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cochlear : Ord Minnett rates COH as Lighten

03/16/2020 | 08:41pm EST

Cochlear Ltd has confirmed the widespread cancellation of elective surgery will affect sales and has withdrawn FY20 guidance. Ord Minnett considers the decision to acknowledge the impending drop in earnings is commendable.

However, the company is unable to provide any clarity on the magnitude of the decline. The broker retains a Lighten rating and lowers the target to $160 from $180.

Sector: Health Care Equipment & Services.

Target price is $160.00.Current Price is $176.88. Difference: ($16.88) - (brackets indicate current price is over target). If COH meets the Ord Minnett target it will return approximately -11% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2020 Acquisdata Pty Ltd., source FN Arena

All news about COCHLEAR LIMITED
01/19SENSORION : Says SENS-401 Product Reduces Loss of Residual Hearing; Shares Rise ..
MT
2020COCHLEAR : US Court Denies Cochlear's Appeal in Patent Infringement Case
MT
2020Australia shares fall on COVID-19 vaccine production halt, post sixth weekly ..
RE
2020Australia shares recover ground ahead of cenbank decision; China tensions wei..
RE
2020Xero's Net Profit Jumps as Customer Growth Continues in Pandemic -- Update
DJ
2020Australia shares end at over 7-mth high as restrictions ease in Victoria
RE
2020COCHLEAR LIMITED : annual earnings release
2020Australia shares fall as record virus cases dent investor sentiment
RE
2020Australia shares rise on stimulus, vaccine hopes
RE
2020Australian companies race to raise capital, share placements top $6 billion
RE
More news
Financials
Sales 2021 1 435 M 1 108 M 1 108 M
Net income 2021 195 M 150 M 150 M
Net cash 2021 239 M 185 M 185 M
P/E ratio 2021 65,8x
Yield 2021 0,50%
Capitalization 13 081 M 10 094 M 10 098 M
EV / Sales 2021 8,95x
EV / Sales 2022 7,55x
Nbr of Employees 4 000
Free-Float 99,4%
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | MarketScreener
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 195,54 AUD
Last Close Price 197,90 AUD
Spread / Highest target 21,8%
Spread / Average Target -1,19%
Spread / Lowest Target -30,3%
EPS Revisions
Managers and Directors
NameTitle
Diggory William Howitt President, CEO, Executive Director & MD
Roderick Holliday-Smith Chairman
Stuart Sayers Chief Financial Officer & President-Services
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COCHLEAR LIMITED4.71%10 040
ABBOTT LABORATORIES3.06%193 340
MEDTRONIC PLC-0.48%156 919
STRYKER CORPORATION-2.09%90 163
BECTON, DICKINSON AND COMPANY3.41%75 258
HOYA CORPORATION-4.52%48 809